Annual CFF
-$1.39 M
-$4.71 M-141.91%
30 September 2023
Summary:
Universe Pharmaceuticals annual cash flow from financing activities is currently -$1.39 million, with the most recent change of -$4.71 million (-141.91%) on 30 September 2023. During the last 3 years, it has fallen by -$27.97 million (-105.23%). UPC annual CFF is now -105.23% below its all-time high of $26.58 million, reached on 30 September 2021.UPC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UPC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -105.2% | - | - |
| 5 y5 years | +91.3% | - | - |
UPC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -105.2% | at low | ||||
| 5 y | 5 years | -105.2% | +91.3% | ||||
| alltime | all time | -105.2% | +91.3% |
Universe Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | -$1.39 M(-141.9%) | - | - |
| Sept 2022 | $3.32 M(-87.5%) | - | - |
| Sept 2021 | $26.58 M(+5554.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | $470.10 K(-102.9%) | - | - |
| Sept 2019 | -$16.00 M(+225.6%) | - | - |
| Sept 2018 | -$4.91 M | - | - |
FAQ
- What is Universe Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Universe Pharmaceuticals?
What is Universe Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of UPC is -$1.39 M
What is the all time high annual CFF for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high annual cash flow from financing activities is $26.58 M